The mixture of flavonoid glycosides obtained from the
n-BuOH fraction of the ethanolic extract of
R. rugosum was subjected to a series of column chromatographic separations to isolate compounds 1-5, namely; quercetin-3-
O-
α-L- rhamnopyranoside (
1), quercetin-3-
O-
β-D-xyloside (
2), quercetin, 3-
O-
α-L-arabinopyranoside,7-
O-
α-L-rhamnopyranoside (
3), kaempferol 3-
O-
α-L-arabinopyranoside, 7-
O-
α-L-rhamnopyranoside (
4) and rutin (
5). Their structures were established via mass and NMR spectroscopy including 2D NMR techniques and through comparison with the reported data in the literature (
6-
13).
Quercetin; 3-O-α-L-arabinopyranoside, 7-O-α-L-rhamnopyranoside (3)
Yellow crystalline solid (75 mg), M.p. 248-250ºC: EIMS m/z (rel. int.): 302 (100), 270 (10), 152 (27), 134 (28). HRFABMS (-ve ion mode): m/z 579.0625 calcd. for C26H27O15, 579.0633. 1H-NMR (400 MHz, DMSO-d6) δ: 6.44 (1H, d, J = 2.0 Hz, H-6), 6.78 (1H, d, J = 2.0 Hz, H-8), 6.82 (1H, d, J = 8.0 Hz, H-5′), 7.56 (1H, d, J = 2.2 Hz, H-2′), 7.70 (1H, dd, J = 8.0, 2.2 Hz, H-6′), 5.56 (1H, brs, H-1′′′), 5.30 (1H, d, J = 4.5 Hz, H-1′′), 3.76 (1H, dd, J = 8.4, 4.7 Hz, H-2′′), 3.53 (1H, m, H-3′′), 3.63 (1H, m, H-4′′), 3.24 (1H, m, H-5a′′), 3.62 (1H, m, H-5b′′), 3.5 (1H, m, H-2′′′), 3.3 (1H, m, H-3′′′), 3.1 (1H, m, H-4′′′), 3.2 (1H, m, H-5′′′), 1.12 (3H, d, J = 5.5 Hz, H-6′′), 13C-NMR (100 MHz, DMSO-d6) δ: 156.7 (C-2), 133.8 (C-3), 177.6 (C-4), 160.8 (C- 5), 98.4 (C-6), 161.6 (C-7), 94.3 (C-8), 156.8 (C-9), 105.5 (C-10), 120.7 (C-1′), 115.8 (C-2′), 145.0 (C-3′), 148.8 (C-4′), 115.2 (C-5′), 122.1 (C-6′), 101.2 (C-1′′), 70.2 (C-2′′), 71.5 (C-3′′), 65.9 (C-4′′), 64.2 (C-5′′), 99.4 (C-1′′′), 70.3 (C-2′′′), 70.4 (C-3′′′), 71.6 (C-4′′′), 70.0 (C-5′′′), 17.8 (C-6′′′).
The major compound 3 was derivatized into its hexaacetate derivative (3a) and analyzed through HRFABMS and NMR. The major flavonoid diglycoside (
3) and its hexaacetate (3a) were screened for cytotoxicity against the human cancer cell line, namely, HepG2 (hepatocellular carcinoma cell line). From the results shown in
Table 1 and
Figures 1 and
2, it could be seen that compound 3 shows a significant cytotoxic activity against the liver carcinoma cell line (IC
50 = 0.86 μg/mL), while the acetylated compound 3a shows a lower cytotoxic activity (IC
50 = 3.50 μg/mL) compared to the standard drug doxorubicin (IC
50 = 0.60 μg/mL).
| Tumor cell line | Extract and compounds conc. μg/mL | n-butanol extract | Compound 3 | Compound 3a | Doxorubicin c |
|---|
| HepG2 | 0.000 | 1.000 ± 0.000 | 1.000 ± 0.000 | 1.000 ± 0.000 | 1.000 ± 0.000 |
| 1.000 | 0.973 ± 0.180a | 0.485 ± 0.186 | 0.847 ± 0.115 a | 0.347 ± 0.117 |
| 2.500 | 0.678 ± 0.172 a | 0.477 ± 0.161 | 0.597 ± 0.149 | 0.350 ± 0.136 |
| 5.000 | 0.479 ± 0.227 | 0.291 ± 0.070 | 0.358 ± 0.117 | 0.359 ± 0.124 |
| 10.000 | 0.430 ± 0.159 | 0.249 ± 0.089 | 0.360 ± 0.136 | 0.345 ± 0.115 |
| bIC50 | | 4.78 μg/mL | 0.86 μg/mL | 3.50 μg/mL | 0.60 μg/mL |
The effects of different concentrations of the n-butanol extract, compounds 3 and 3a on HepG2 cell survival as assessed through the SRB Cytotoxic Assay
The IC50-values of n-butanol extract, compounds 3 and 3a
Structure of compounds 3 and 3a
Quercetin-3-
O-
α-L-rhamnopyranoside (
1), quercetin-3-
O-
β-D-xyloside (
2), quercetin, 3-
O-
α-L-arabinopyranoside,7-
O-
α-L- rhamnopyranoside (
3), kaempferol 3-
O-
α-L-arabinopyranoside, 7-
O-
α-L-rhamnopyranoside (
4) and rutin (
5) have been isolated for the first time from
Rapistrum. By means of chemical methods and spectroscopic analyses, the structures of these compounds (
1-
5) were established. There were no previous published reports dealing with the NMR data of the flavonoid diglycoside 3.
Compound 3 was obtained as a yellow crystalline solid. The HRFABMS of 3 exhibited a pseudomolecular ion peak [M-H]- at m/z 579.0625 (calcd. for C26H27O15, 579.0633) consistent with the molecular formula of C26H27O15. The EIMS spectrum showed different peaks of aglycone at m/z 302, 270, 154 and 150. The UV spectrum exhibited characteristic absorption maxima for a flavonoid glycoside at λmax (nm), (MeOH): 260, 300 (sh). The EIMS gave a peak at m/z 302 due to successive losses of sugar moieties. The 1H NMR spectrum displayed a signal at δ 12.50 for a chelated hydroxyl group and two meta coupled protons of ring A at δ 6.44 (d, J = 2.0 Hz) and 6.78 (d, J = 2.0 Hz). It further showed three aromatic protons of ring B forming an ABX system at δ 6.82 (d, J = 8.0 Hz, H-5), δ 7.56 (d, J = 2.2 Hz, H-2) and δ 7.70 (dd, J = 8.0, 2.2 Hz, H-6′). In the aliphatic region, an anomeric proton signal at δ 5.30 (d, J = 4.5 Hz), together with two oxymethylene protons observed at δ 3.24 (m) and δ 3.62 (m) were indicative to the presence of α-L-arabinopyranoside moiety. The second anomeric proton was observed at δ 5.56 as (brs). The 1H NMR spectrum further showed signals of oxymethine protons in the range of δ 3.76-3.10 and the methyl protons resonated at δ 1.12 (d, J = 5.5 Hz) which was characteristic for α-L-rhamnopyranoside moiety.
The
13C NMR and DEPT spectra showed twenty-six signals comprising one methyl, one methylene, fourteen methine and ten quaternary carbons. The signals at
δ 156.7, 133.8, 177.6 and 105.5 were typical of C-2, C-3, C-4 and C-10 of a flavonol moiety. The signals of two anomeric carbons of the sugar moieties appeared at
δ 101.2 and 99.4. Assignment of all
1H and
13C resonances was proved through their comparison with the reported data in the literature (
6-
13). Acid hydrolysis of 3 provided L-arabinose and L-rhamnose and it was confirmed through the TLC of sugars with their standards.
In addition, the major flavonoid diglycoside (
3) and its acetylated form (3a) were screened for cytotoxicity against the human cancer cell line, namely, HepG2 (hepatocellular carcinoma cell line).
Previous studies, however, proved the antitumor activity of flavonoids and even aimed at elucidating the structure-activity relationships in order to develop new anticancer drugs (
14). This is the first report for the cytotoxic activity of these compounds. This finding may help to show the structural requirements implicated in the anticancer activity of flavonoids, with the goal of rationalizing their development as antitumor agents.